These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3384474)

  • 1. Purification and characterization of toxin B from Clostridium difficile.
    Meador J; Tweten RK
    Infect Immun; 1988 Jul; 56(7):1708-14. PubMed ID: 3384474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and some properties of cytotoxin produced by Clostridium difficile.
    Katoh T; Honda T; Miwatani T
    Microbiol Immunol; 1988; 32(6):551-64. PubMed ID: 3173147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile.
    Banno Y; Kobayashi T; Kono H; Watanabe K; Ueno K; Nozawa Y
    Rev Infect Dis; 1984; 6 Suppl 1():S11-20. PubMed ID: 6426016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterisation of two forms of toxin B produced by Clostridium difficile.
    Torres JF; Lönnroth I
    FEBS Lett; 1988 Jun; 233(2):417-20. PubMed ID: 3133248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and characterization of urease from schizosaccharomyces pombe.
    Lubbers MW; Rodriguez SB; Honey NK; Thornton RJ
    Can J Microbiol; 1996 Feb; 42(2):132-40. PubMed ID: 8742356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterisation of toxin B from a strain of Clostridium difficile that does not produce toxin A.
    Torres JF
    J Med Microbiol; 1991 Jul; 35(1):40-4. PubMed ID: 1906544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of cytotoxin from the crude extract of Pseudomonas aeruginosa.
    Hayashi T; Kamio Y; Terawaki Y
    Microb Pathog; 1989 Feb; 6(2):103-12. PubMed ID: 2497292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of alpha-toxin of Clostridium oedematiens type A.
    Izumi N; Kondo H; Ohishi I; Sakaguchi G
    Jpn J Med Sci Biol; 1983 Jun; 36(3):135-46. PubMed ID: 6632349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of toxins A and B of Clostridium difficile.
    Sullivan NM; Pellett S; Wilkins TD
    Infect Immun; 1982 Mar; 35(3):1032-40. PubMed ID: 7068210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutaredoxin from rabbit bone marrow. Purification, characterization, and amino acid sequence determined by tandem mass spectrometry.
    Hopper S; Johnson RS; Vath JE; Biemann K
    J Biol Chem; 1989 Dec; 264(34):20438-47. PubMed ID: 2684977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of Clostridium difficile toxin A by affinity chromatography on immobilized thyroglobulin.
    Krivan HC; Wilkins TD
    Infect Immun; 1987 Aug; 55(8):1873-7. PubMed ID: 3112015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and properties of Clostridium difficile cytotoxin B.
    Pothoulakis C; Barone LM; Ely R; Faris B; Clark ME; Franzblau C; LaMont JT
    J Biol Chem; 1986 Jan; 261(3):1316-21. PubMed ID: 3944088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of an enterotoxin from Bacteroides fragilis.
    Van Tassell RL; Lyerly DM; Wilkins TD
    Infect Immun; 1992 Apr; 60(4):1343-50. PubMed ID: 1548060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential cytotoxic effects of toxins A and B isolated from Clostridium difficile.
    Rothman SW; Brown JE; Diecidue A; Foret DA
    Infect Immun; 1984 Nov; 46(2):324-31. PubMed ID: 6500693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterisation of Clostridium difficile toxin A by bovine thyroglobulin affinity chromatography and dissociation in denaturing conditions with or without reduction.
    Kamiya S; Reed PJ; Borriello SP
    J Med Microbiol; 1989 Sep; 30(1):69-77. PubMed ID: 2778794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of Clostridium sordellii hemorrhagic toxin and cross-reactivity with Clostridium difficile toxin A (enterotoxin).
    Martinez RD; Wilkins TD
    Infect Immun; 1988 May; 56(5):1215-21. PubMed ID: 3128481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A toxic thionin from Pyrularia pubera: purification, properties, and amino acid sequence.
    Vernon LP; Evett GE; Zeikus RD; Gray WR
    Arch Biochem Biophys; 1985 Apr; 238(1):18-29. PubMed ID: 3985614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile toxin B: characterization and sequence of three peptides.
    Bisseret F; Keith G; Rihn B; Amiri I; Werneburg B; Girardot R; Baldacini O; Green G; Nguyen VK; Monteil H
    J Chromatogr; 1989 May; 490(1):91-100. PubMed ID: 2474559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dithiothreitol generates an activated 250,000 mol. wt form of Clostridium difficile toxin B.
    Shoshan MC; Bergman T; Thelestam M; Florin I
    Toxicon; 1993 Jul; 31(7):845-52. PubMed ID: 8212030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of immunological properties and cytotoxic effects of Clostridium difficile toxin B and Clostridium sordellii toxin L.
    Baldacini O; Girardot R; Green GA; Rihn B; Monteil H
    Toxicon; 1992 Feb; 30(2):129-40. PubMed ID: 1557784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.